6 Stocks That Are Outperforming the Market

Accenture, Adove among companies that have beated the S&P 500 over the past year

Author's Avatar
Dec 28, 2017
Article's Main Image

According to GuruFocus' All-in-One Guru Screener, the following are some of the stocks that have outperformed the Standard & Poor's 500 Index over the last 12 months and were bought by gurus during the last quarter.

Ambev SA ADR (ABEV) has a market cap of $100.56 billion. It has outperformed the S&P 500 Index by 15.7% over the past 12 months.

Its shares are trading with a price-book (P/B) ratio of 6.91. According to the discounted cash flow (DCF) calculator, the stock is undervalued at $6.26 per share. The stock price is currently 32.35% above its 52-week low and 10.95% below its 52-week high.

The company produces, distributes and sells beer and other non-alcoholic products. It has a profitability and growth rating of 6 out of 10. Its return on equity (ROE) of 18.98% and return on assets (ROA) of 10.81% are outperforming 89% of other companies in the Global Beverages – Brewers industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 2.51 is above the industry median of 0.60.

The company’s largest shareholder among the gurus is Manning & Napier Advisors, Inc with 0.34% of outstanding shares followed by Howard Marks (Trades, Portfolio) with 0.16%.

With a market cap of $8.43 billion, Abiomed Inc. (ABMD) has outperformed the S&P 500 Index by 49.4% over the past 12 months.

Its shares are trading with a P/B ratio of 13.93. According to the DCF calculator, the stock is overpriced at $190.63 per share. The stock price is currently 84.13% above its 52-week low and 4.82% below its 52-week high.

The medical device company has a profitability and growth rating of 8 out of 10. Its ROE of 18.90% and ROA of 16.05% are outperforming 87% of other companies in the Global Medical Devices industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio is 16.49 is above the industry median of 2.87.

PRIMECAP Management (Trades, Portfolio) is the largest shareholder of the company among the gurus with 9.54% of outstanding shares followed by Jim Simons (Trades, Portfolio) with 2.46% and Chuck Royce (Trades, Portfolio) with 0.05%.

Abbott Laboratories (ABT) has a market cap of $99.09 billion. It has outperformed the S&P 500 Index by 33.1% over the past 12 months.

Its shares are trading with a P/B ratio of 3.09. According to the DCF calculator, the stock is overpriced at $56.93 per share. The stock price is currently 50.17% above its 52-week low and 0.65% below its 52-week high.

The health care company has a profitability and growth rating of 7 out of 10. Its ROE of 7.71% and ROA of 3.43% are underperforming 58% of other companies in the Global Medical Devices industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 0.47 is below the industry median of 2.87.

The company’s largest shareholder among the gurus is Vanguard Health Care Fund (Trades, Portfolio) with 1.21% of outstanding shares followed by PRIMECAP Management (Trades, Portfolio) with 0.84% and Diamond Hill Capital (Trades, Portfolio) with 0.63%.

With a market cap of $17.19 billion, Aluminum Corporation of China Ltd. ADR (ACH) has outperformed the S&P 500 Index by 55.4% over the past 12 months.

Its shares are trading with a P/B ratio of 3.16 According to the DCF calculator, the stock is overpriced at $17.84 per share. The stock price is currently 79.66% above its 52-week low and 24.21% below its 52-week high.

The producer of aluminum has a profitability and growth rating of 2 out of 10. Its ROE of 1.20% and ROA of 0.27% are outperforming 96% of other companies in the Global Aluminum industry. Financial strength has a rating of 4 out of 10 with a cash-debt ratio of 0.32.

Simons is the largest shareholder of the company among the gurus with 0.1% of outstanding shares.

Accenture PLC Class A (ACN) has a market cap of $97.95 billion. It has outperformed the S&P 500 Index by 14.4% over the past 12 months.

Its shares are trading with a P/B ratio of 10.96. According to the DCF calculator, the stock is overpriced at $154.2 per share. The stock price is currently 37.30% above its 52-week low and 2.68% below its 52-week high.

The professional service company has a profitability and growth rating of 8 out of 10. Its ROE of 43.01% and ROA of 16.41% are outperforming 90% of other companies in the Global Information Technology Services industry. Financial strength has a rating of 8 out of 10. The cash-debt ratio of 164.73 is above the industry median of 6.56.

The company’s largest shareholder among the gurus is Jeremy Grantham (Trades, Portfolio) with 0.36% of outstanding shares followed by Pioneer Investments (Trades, Portfolio) with 0.16%, MS Global Franchise Fund (Trades, Portfolio) with 0.08% and Wallace Weitz (Trades, Portfolio) with 0.03%.

With a market cap of $86.05 billion, Adobe Systems Inc. (ADBE) has outperformed the S&P 500 Index by 46.9% over the past 12 months.

Its shares are trading with a P/B ratio of 10.14. According to the DCF calculator, the stock is overpriced at $174.56 per share. The stock price is currently 70.35% above its 52-week low and 6.29% below its 52-week high.

The company offers a line of software and services and has a profitability and growth rating of 8 out of 10. Its ROE of 21.47% and ROA of 12.54% are outperforming 83% of other companies in the Global Software - Application industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 3.09 is below the industry median of 6.56.

PRIMECAP Management (Trades, Portfolio) is the largest shareholder of the company among the gurus with 4.87% of outstanding shares followed by Frank Sands (Trades, Portfolio) with 1.15%, Spiros Segalas (Trades, Portfolio) with 0.92% and Steve Mandel (Trades, Portfolio) with 0.8%.

Disclosure: I do not own any shares of any stocks mentioned in this article.